01 7Astellas Pharma Canada Inc.
01 22044746
02 32202058
03 22341568
01 7Micafungin Sodium
01 5Lyophilized Powder for Injection
02 2Lyophilized powder for injection
01 22011-06-17
02 32015-09-29
03 22020-06-29
Patent Expiration Date : 2015-09-29
Date Granted : 2007-11-06
Brand Name : MYCAMINE
Patent Number : 2202058
Filing Date : 1995-09-29
Strength per Unit : 25mg
Dosage Form : Lyophilized Powder for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-09-29
Date Granted : 2007-11-06
Patent Expiration Date : 2015-09-29
Date Granted : 2007-11-06
Brand Name : MYCAMINE
Patent Number : 2202058
Filing Date : 1995-09-29
Strength per Unit : 50mg
Dosage Form : Lyophilized Powder for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-09-29
Date Granted : 2007-11-06
Patent Expiration Date : 2015-09-29
Date Granted : 2007-11-06
Brand Name : MYCAMINE
Patent Number : 2202058
Filing Date : 1995-09-29
Strength per Unit : 100 mg
Dosage Form : Lyophilized powder for injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2015-09-29
Date Granted : 2007-11-06
Patent Expiration Date : 2011-06-17
Date Granted : 2001-08-07
Brand Name : MYCAMINE
Patent Number : 2044746
Filing Date : 1991-06-17
Strength per Unit : 25mg
Dosage Form : Lyophilized Powder for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2011-06-17
Date Granted : 2001-08-07
Patent Expiration Date : 2011-06-17
Date Granted : 2001-08-07
Brand Name : MYCAMINE
Patent Number : 2044746
Filing Date : 1991-06-17
Strength per Unit : 50mg
Dosage Form : Lyophilized Powder for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2011-06-17
Date Granted : 2001-08-07
Patent Expiration Date : 2020-06-29
Date Granted : 2011-10-25
Brand Name : MYCAMINE
Patent Number : 2341568
Filing Date : 2000-06-29
Strength per Unit : 50mg
Dosage Form : Lyophilized Powder for Injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-06-29
Date Granted : 2011-10-25
Patent Expiration Date : 2020-06-29
Date Granted : 2011-10-25
Brand Name : MYCAMINE
Patent Number : 2341568
Filing Date : 2000-06-29
Strength per Unit : 100 mg
Dosage Form : Lyophilized powder for injection
Human Or VET : Human
Route of Administration : Intravenous
Patent Expiration Date : 2020-06-29
Date Granted : 2011-10-25
LOOKING FOR A SUPPLIER?
